Literature DB >> 1432634

Variability of inversion of (R)-flurbiprofen in different species.

S Menzel-Soglowek1, G Geisslinger, W S Beck, K Brune.   

Abstract

The anti-inflammatory activity of 2-arylpropionic acids like flurbiprofen appears to be due to the S enantiomers only. A unique characteristic of the metabolism of this class of drugs is inversion of configuration. The present study examines whether chiral inversion occurs after administration of the optically pure flurbiprofen enantiomers to various species (i.e., dogs, guinea pigs, rats, and gerbils). Concentrations of the enantiomers in plasma were analyzed by a stereoselective high-performance liquid chromatographic assay with a chiral alpha 1-acid glycoprotein column. Pharmacokinetic parameters of the flurbiprofen enantiomers were evaluated with a two-compartment computer model. Inversion of (R)-flurbiprofen to its optical antipode occurred to a variable extent in the dog [fraction inverted (Fi) = 0.39; n = 3] and the guinea pig (Fi = 1.00; n = 3) and to a much lower extent in the rat (Fi = 0.02; n = 3) and the gerbil (Fi = 0.05; n = 3). After intravenous administration of (S)-flurbiprofen to dogs, guinea pigs, rats, and gerbils, (R)-flurbiprofen was not detected in plasma (limit of quantification was 0.05 microgram/100 microL of plasma).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432634     DOI: 10.1002/jps.2600810909

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Pharmacokinetic parameters of (R)-(-) and (S)-(+)-flurbiprofen in dairy bovines.

Authors:  L Igarza; A Soraci; N Auza; H Zeballos
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

Review 2.  Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research.

Authors:  Bruno Georg Oertel; Jörn Lötsch
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

3.  Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf-life and pharmacology.

Authors:  A A van Sorge; P H Wijnen; J L van Delft; V M Coré-Bodelier; N J van Haeringen
Journal:  Pharm World Sci       Date:  1999-04

4.  Concentration-dependent plasma protein binding of flurbiprofen in the rat: an in vivo microdialysis study.

Authors:  P A Evrard; J Cumps; R K Verbeeck
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

Authors:  J Lötsch; G Geisslinger; P Mohammadian; K Brune; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

6.  Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers.

Authors:  G Geisslinger; J Lötsch; S Menzel; G Kobal; K Brune
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.